163 related articles for article (PubMed ID: 37485727)
1. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine for Alzheimer's disease.
Birks JS; Grimley Evans J
Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
[TBL] [Abstract][Full Text] [Related]
3. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
5. Cholinesterase inhibitors for the treatment of delirium in non-ICU settings.
Yu A; Wu S; Zhang Z; Dening T; Zhao S; Pinner G; Xia J; Yang D
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012494. PubMed ID: 29952000
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine patch reduces the incidence of postoperative delirium in older patients with cognitive impairment.
Youn YC; Shin HW; Choi BS; Kim S; Lee JY; Ha YC
Int J Geriatr Psychiatry; 2017 Oct; 32(10):1079-1084. PubMed ID: 27561376
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
Oldenbeuving AW; de Kort PL; Jansen BP; Kappelle LJ; Roks G
BMC Neurol; 2008 Sep; 8():34. PubMed ID: 18803862
[TBL] [Abstract][Full Text] [Related]
8. Rivastigmine for vascular cognitive impairment.
Birks J; McGuinness B; Craig D
Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
[TBL] [Abstract][Full Text] [Related]
9. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.
Gamberini M; Bolliger D; Lurati Buse GA; Burkhart CS; Grapow M; Gagneux A; Filipovic M; Seeberger MD; Pargger H; Siegemund M; Carrel T; Seiler WO; Berres M; Strebel SP; Monsch AU; Steiner LA
Crit Care Med; 2009 May; 37(5):1762-8. PubMed ID: 19325490
[TBL] [Abstract][Full Text] [Related]
10. Rivastigmine in the treatment of delirium in older people: a pilot study.
Overshott R; Vernon M; Morris J; Burns A
Int Psychogeriatr; 2010 Aug; 22(5):812-8. PubMed ID: 20353624
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterase inhibitor initiation in hospital setting.
Wagle KC; Taffet GE; Natali B
J Am Geriatr Soc; 2011 Oct; 59(10):1988-9. PubMed ID: 22091527
[No Abstract] [Full Text] [Related]
12. Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.
Henstra MJ; Feenstra TC; Kok RM; Spaans HP; van Exel E; Dols A; Oudega M; Vergouwen ACM; van der Loo A; Bet PM; Loer SA; Eikelenboom M; Sienaert P; Lambrichts S; Bouckaert F; Bosmans JE; van der Velde N; Beekman ATF; Stek ML; Rhebergen D
Front Psychiatry; 2022; 13():953686. PubMed ID: 35911242
[TBL] [Abstract][Full Text] [Related]
13. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial.
Brawman-Mintzer O; Tang XC; Bizien M; Harvey PD; Horner MD; Arciniegas DB; Raskind M; Johnson-Greene L; Martineau RJ; Hamner M; Rodriguez-Suarez M; Jorge RE; McGarity S; Wortzel HS; Wei Y; Sindowski T; Mintzer J; Kindy AZ; Donovan K; Reda D
J Neurotrauma; 2021 Jul; 38(14):1943-1952. PubMed ID: 33514274
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke].
Litvineneko IV; Odinak MM; Khlystov IuV; Perstnev SV; Fedorov BB
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):36-41. PubMed ID: 21389938
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterase inhibitors for Parkinson's disease dementia.
Maidment I; Fox C; Boustani M
Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494
[TBL] [Abstract][Full Text] [Related]
17. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Feldman HH; Ferris S; Winblad B; Sfikas N; Mancione L; He Y; Tekin S; Burns A; Cummings J; del Ser T; Inzitari D; Orgogozo JM; Sauer H; Scheltens P; Scarpini E; Herrmann N; Farlow M; Potkin S; Charles HC; Fox NC; Lane R
Lancet Neurol; 2007 Jun; 6(6):501-12. PubMed ID: 17509485
[TBL] [Abstract][Full Text] [Related]
18. Rivastigmine for Alzheimer's disease.
Birks J; Grimley Evans J; Iakovidou V; Tsolaki M; Holt FE
Cochrane Database Syst Rev; 2009 Apr; (2):CD001191. PubMed ID: 19370562
[TBL] [Abstract][Full Text] [Related]
19. Effect of Rivastigmine (Acetyl Cholinesterase Inhibitor) versus Placebo on Manic Episodes in Patients with Bipolar Disorders: Results from a Double Blind, Randomized, Placebo-Controlled Clinical Trial.
Keshavrzi A; Rezaei H; Haghighi M; Jahangard L
Neuropsychobiology; 2019; 78(4):200-208. PubMed ID: 31315114
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
Ballard C; Margallo-Lana M; Juszczak E; Douglas S; Swann A; Thomas A; O'Brien J; Everratt A; Sadler S; Maddison C; Lee L; Bannister C; Elvish R; Jacoby R
BMJ; 2005 Apr; 330(7496):874. PubMed ID: 15722369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
